Thousand Oaks Biologics at CPHI Frankfurt 2025
Thousand Oaks Biologics, a leading Asia-based CRDMO, announced its participation in CPHI Frankfurt 2025, held from October 28-30.
The company will showcase its integrated ADC CRDMO solutions and media innovation for industrialization at Booth 4.1H54 in the Bioproduction Zone.
Antibody-drug conjugates (ADCs) are a key driver of China's innovative drug globalization.
- Event: CPHI Frankfurt 2025
- Location: Booth 4.1H54, Bioproduction Zone
- Dates: October 28-30, 2025
Author's summary: Thousand Oaks Biologics participates in CPHI Frankfurt 2025.
More News
- HowGood, The World’s Largest Agricultural Emissions Database, Joins Forces with PACT to Unlock Standardized Decarbonization Across the Food Supply Chain
- Dexter Council Approves DDA Plan, Grants Tax Break, and Talks Golf Carts - The Sun Times News
- 7 basic science discoveries that changed the world
- Andy Cohen Praises a Dallas Church for its Reponse to Gov. Abbott's War on Crosswalks
- From MRI to Ozempic: breakthroughs that show why fundamental research must be protected
- ‘Like It Was Yesterday’: The 1985 Villanova Football Team Reunited For Its 40th Anniversary
- Glaude urges a simple reponse to MAGA: 'You're lying' – Baptist News Global
- Elaine Hendrix on Vegan Living, ‘Dancing With the Stars’, and Life After ‘The Parent Trap’
- Gmail Data Breach: 183 million accounts exposed in massive leak
- Black holes are encircled by thin rings of light. This physicist wants to see one